Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H12O6P2S2 |
| Molecular Weight | 330.255 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CSC1=CC=C(SC(P(O)(O)=O)P(O)(O)=O)C=C1
InChI
InChIKey=ONKXKYBOHBTXEF-UHFFFAOYSA-N
InChI=1S/C8H12O6P2S2/c1-17-6-2-4-7(5-3-6)18-8(15(9,10)11)16(12,13)14/h2-5,8H,1H3,(H2,9,10,11)(H2,12,13,14)
| Molecular Formula | C8H12O6P2S2 |
| Molecular Weight | 330.255 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:57:28 GMT 2025
by
admin
on
Mon Mar 31 20:57:28 GMT 2025
|
| Record UNII |
EZH47ZB2YF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
151425-91-1
Created by
admin on Mon Mar 31 20:57:28 GMT 2025 , Edited by admin on Mon Mar 31 20:57:28 GMT 2025
|
PRIMARY | |||
|
EZH47ZB2YF
Created by
admin on Mon Mar 31 20:57:28 GMT 2025 , Edited by admin on Mon Mar 31 20:57:28 GMT 2025
|
PRIMARY | |||
|
9820915
Created by
admin on Mon Mar 31 20:57:28 GMT 2025 , Edited by admin on Mon Mar 31 20:57:28 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
TRK-530 is a novel bisphosphonate derivative. We examined the anti-inflammatory effects of TRK-530 on adjuvant arthritis (AA) rats. When TRK-530 at a dose of 2.5 mg/kg was administered for 2 weeks to AA rats, it inhibited destructive changes in arthritic joints such as paw edema, bone loss and joint degeneration.
|
